Company Filing History:
Years Active: 1989
Title: The Innovations of Erling Myhre
Introduction
Erling Myhre is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of proteins with immunoglobulin binding capabilities. His work has implications for various applications in medical and pharmaceutical research.
Latest Patents
Erling Myhre holds a patent for "Protein L and subfragments thereof, with immunoglobulin binding." This invention relates to a new protein L and its subfragments that exhibit binding activity for all classes of immunoglobulins from different species. The patent also describes a process for preparing the protein and its subfragments, a reagent kit, a pharmaceutical composition, and strain 312 of P. magnus. The preparation process involves treating the microorganism P. magnus 312 with proteolytic enzymes or mutanolysin. He has 1 patent to his name.
Career Highlights
Erling Myhre is associated with Hightech Receptor Ab, where he continues to advance his research and innovations. His work in the company focuses on developing novel biotechnological solutions that can enhance the understanding and treatment of various diseases.
Collaborations
Erling has collaborated with notable colleagues such as Lars Bjorck and Mats Erntell. Their combined expertise has contributed to the success of their projects and the advancement of their research.
Conclusion
Erling Myhre's contributions to the field of biotechnology, particularly through his patent on Protein L, highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the development of new therapeutic solutions.